Cannabinoid Receptors and the Cytokine Network

  • Thomas W. Klein
  • Catherine Newton
  • Herman Friedman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 437)

Abstract

Marijuana components, especially Δ9-tetrahydrocannabinol (THC), have been shown to modulate immune function in both in vivoand in vitroparadigms1. However, the impact of drug-induced immunomodulation on host resistance to infection is uncertain and only a few studies have been reported coupling animal infection models and drug treatment. The molecular mechanisms of drug-induced immunomodulation are also unknown. An endogenous cannabinoid system has been described over the past few years composed of receptors and ligands2 and evidence suggests that cells of the immune system express these receptors3-5. However, the precise role of these receptors in drug-induced immunomodulation is not clear.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klein, T., Friedman, H. and Specter, S., Marijuana, immunity, and infection, J. Neuroimmunol., in press, (1998).Google Scholar
  2. 2.
    Mechoulam, R., Hanus, L. and B.R., M., Search for endogenous ligands of the cannabinoid receptor., Biochem. Pharmacol., 48:1537, (1994).PubMedCrossRefGoogle Scholar
  3. 3.
    Schatz, A.R., Lee, M., Condie, R.B., Pulaski, J.T. and Kaminski, N.E., Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system., Toxi-col. appl. Pharm., 142:278, (1997).CrossRefGoogle Scholar
  4. 4.
    Derocq, J., Segui, M., Marchand, J., LeFur, G. and Casellas, P., Cannabinoids enhance human B-cell growth at low nanomolar concentrations., FEBS Letters, 369:177, (1995).PubMedCrossRefGoogle Scholar
  5. 5.
    Daaka, Y., Friedman, H. and Klein, T.W., Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation., J. Pharmacol. Exp. Ther, 276:776, (1996).PubMedGoogle Scholar
  6. 6.
    Klein, T.W., Newton, C., Widen, R. and Friedman, H., Δ9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila., J. Pharmacol. Exp. Ther, 267:635, (199PubMedGoogle Scholar
  7. 7.
    Newton, C.A., Klein, T.W. and Friedman, H., Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection., Infect. Immun., 62:4015, (1994).PubMedGoogle Scholar
  8. 8.
    Kaminski, N.E., Abood, M.E., Kessler, F.K., Martin, B.R. and Schatz, A.R., Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation., Mol. Pharm., 42:736, (1992).Google Scholar
  9. 9.
    Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J.C. and LeFur, G., SR141716A, a potent and selective antagonist of the brain cannabinoid receptor., FEBS Letters, 350:240, (1994).PubMedCrossRefGoogle Scholar
  10. 10.
    Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R. and Vogel, Z., The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling., FEBS Letters, 375:143, (1995).PubMedCrossRefGoogle Scholar
  11. 11.
    Felder, C.C., Joyce, K.E., Briley, E.M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A.L. and Mitchell, R.L., Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors., Mol. Pharmacol., 48:443, (1995).PubMedGoogle Scholar
  12. 12.
    Compton, D.R., Rice, K.C., De Costa, B.R., Razdan, R.K., Melvin, L.S., Johnson, M.R. and Martin, B.R., Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities., J. Pharmacol. Exp. Ther, 265:218, (1993).PubMedGoogle Scholar
  13. 13.
    Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessegue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D. and Ferrara, P., Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor., Biochim. Biophys. Acta, 1307:132, (1996).PubMedCrossRefGoogle Scholar
  14. 14.
    Huffman, J.W., Yu, S., Showalter, V., Abood, M.E., Wiley, J.L., Compton, D.R., Martin, B.R., Bramblett, R.D. and Reggio, P.H., Synthesis and pharmacology of a very potent eannabinoid lacking a phenolic hy-droxyl with high affinity for the CB2 receptor., J. Med. Chem., 39:3875, (1996).PubMedCrossRefGoogle Scholar
  15. 15.
    Allen, J.E. and Maizels, R.M., Th1-Th2: reliable paradigm or dangerous dogma?, Immunol. Today, 18:387, (1997).PubMedCrossRefGoogle Scholar
  16. 16.
    Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J., Le Fur, G. and Casellas, P., A selective inverse agonist for central eannabinoid receptor inhibits mitoge-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1., J. Biol Chem., 272:22330, (1997).PubMedCrossRefGoogle Scholar
  17. 17.
    Galieque, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G. and Casellas, P., Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations., Eur. J. Biochem., 232:54, (1995).CrossRefGoogle Scholar
  18. 18.
    Munro, S., Thomas, K.L. and Abu-Shaar, M., Molecular characterization of a peripheral receptor for cannabinoids., Nature, 365:61, (1993).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Thomas W. Klein
    • 1
  • Catherine Newton
    • 1
  • Herman Friedman
    • 1
  1. 1.University of South FloridaCollege of Medicine Medical Microbiology and ImmunologyTampaUSA

Personalised recommendations